JP2013040142A5 - - Google Patents

Download PDF

Info

Publication number
JP2013040142A5
JP2013040142A5 JP2011178937A JP2011178937A JP2013040142A5 JP 2013040142 A5 JP2013040142 A5 JP 2013040142A5 JP 2011178937 A JP2011178937 A JP 2011178937A JP 2011178937 A JP2011178937 A JP 2011178937A JP 2013040142 A5 JP2013040142 A5 JP 2013040142A5
Authority
JP
Japan
Prior art keywords
ornithine
composition
salt
composition according
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011178937A
Other languages
Japanese (ja)
Other versions
JP2013040142A (en
JP5997425B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2011178937A priority Critical patent/JP5997425B2/en
Priority claimed from JP2011178937A external-priority patent/JP5997425B2/en
Publication of JP2013040142A publication Critical patent/JP2013040142A/en
Publication of JP2013040142A5 publication Critical patent/JP2013040142A5/ja
Application granted granted Critical
Publication of JP5997425B2 publication Critical patent/JP5997425B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (21)

オルニチンまたはその塩、グルタミンまたはその塩、亜鉛およびビタミン類を含有する組成物。 A composition containing ornithine or a salt thereof, glutamine or a salt thereof, zinc and vitamins. オルニチンまたはその塩が、オルニチンとして、組成物に含有されるタンパク質量の10〜70質量%であることを特徴とする請求項1記載の組成物。 The composition according to claim 1, wherein ornithine or a salt thereof is 10 to 70% by mass of the amount of protein contained in the composition as ornithine. オルニチンまたはその塩が、オルニチンとして、組成物全量の5〜45質量%であることを特徴とする請求項1または2記載の組成物。 The composition according to claim 1 or 2, wherein ornithine or a salt thereof is ornithine in an amount of 5 to 45% by mass of the total composition. オルニチンまたはその塩がオルニチンとして800〜1700mg含まれることを特徴とする請求項1から3のいずれか1項記載の組成物。 The composition according to any one of claims 1 to 3, wherein ornithine or a salt thereof is contained in an amount of 800 to 1700 mg as ornithine. グルタミンまたはその塩がグルタミンとして100〜2000mg含まれることを特徴とする請求項1から4のいずれか1項記載の組成物。 The composition according to any one of claims 1 to 4, wherein glutamine or a salt thereof is contained in an amount of 100 to 2000 mg as glutamine. オルニチンまたはその塩とグルタミンまたはその塩との重量組成比がオルニチンおよびグルタミンとして1:4〜9:4である請求項1から5のいずれか1項記載の組成物。 6. The composition according to any one of claims 1 to 5, wherein the weight composition ratio of ornithine or a salt thereof and glutamine or a salt thereof is 1: 4 to 9: 4 as ornithine and glutamine. 亜鉛が0.1〜15mg含まれることを特徴とする請求項1から6のいずれか1項記載の組成物。 The composition according to claim 1, wherein 0.1 to 15 mg of zinc is contained. オルニチンまたはその塩と亜鉛との重量組成比がオルニチンおよび亜鉛として70:3〜10:1である請求項1から7のいずれか1項記載の組成物。 The composition according to any one of claims 1 to 7, wherein a weight composition ratio of ornithine or a salt thereof and zinc is 70: 3 to 10: 1 as ornithine and zinc. ビタミン類がビタミンAおよびビタミンCからなる群から選ばれる1以上のビタミン類を含有する請求項1から8のいずれか1項記載の組成物。 The composition according to any one of claims 1 to 8, wherein the vitamin contains one or more vitamins selected from the group consisting of vitamin A and vitamin C. ビタミンAが10〜600μg含まれることを特徴とする請求項9項記載の組成物。 The composition according to claim 9, comprising 10 to 600 μg of vitamin A. ビタミンCが24〜500mg含まれることを特徴とする請求項9項記載の組成物。 The composition according to claim 9, wherein 24 to 500 mg of vitamin C is contained. オルニチンまたはその塩とビタミンCとの重量組成比がオルニチンとビタミンCとして3:2〜7:2である請求項9または11記載の組成物。 The composition according to claim 9 or 11, wherein the weight composition ratio of ornithine or a salt thereof and vitamin C is 3: 2 to 7: 2 as ornithine and vitamin C. 組成物が粉末または顆粒であることを特徴とする請求項1から12のいずれか1項記載の組成物。 The composition according to claim 1, wherein the composition is a powder or a granule. 酸味料を含有させる工程を含むオルニチンまたはその塩、グルタミンまたはその塩、亜鉛、ビタミン類を含有する組成物の製造方法。 A method for producing a composition containing ornithine or a salt thereof, glutamine or a salt thereof, zinc and vitamins, comprising a step of containing a sour agent. オルニチンまたはその塩が、組成物に含有されるタンパク質量の10〜70質量%であることを特徴とする請求項14記載の製造方法。 The method according to claim 14, wherein ornithine or a salt thereof is 10 to 70% by mass of the amount of protein contained in the composition. 酸味料がクエン酸である請求項14または15記載の製造方法。 The method according to claim 14 or 15, wherein the acidulant is citric acid. 請求項1から13のいずれか1項記載の組成物を含有、混合、溶解させた50〜240mlの飲料。 A beverage of 50 to 240 ml containing, mixing and dissolving the composition according to any one of claims 1 to 13. pHが3.0〜4.0であることを特徴とする請求項17記載の飲料。 The beverage according to claim 17, wherein the pH is 3.0 to 4.0. 請求項1から13のいずれか1項記載の組成物を有効成分とする栄養改善用組成物。 The composition for nutrition improvement which uses the composition of any one of Claim 1 to 13 as an active ingredient. 栄養改善が褥瘡の予防または改善、術後回復に関する栄養改善である請求項19記載の栄養改善用組成物。 The nutrition improving composition according to claim 19, wherein the nutrition improvement is prevention or improvement of pressure ulcer and nutrition improvement related to postoperative recovery. 請求項1から13のいずれか1項記載の組成物、または請求項19もしくは20記載の栄養改善用組成物の1回あたりの摂取量が2.0〜8.0 gに調整された粉末飲料。A powdered beverage in which the intake per time of the composition according to any one of claims 1 to 13 or the nutritional improvement composition according to claim 19 or 20 is adjusted to 2.0 to 8.0 g.
JP2011178937A 2011-08-18 2011-08-18 Ornithine-containing composition Active JP5997425B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011178937A JP5997425B2 (en) 2011-08-18 2011-08-18 Ornithine-containing composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011178937A JP5997425B2 (en) 2011-08-18 2011-08-18 Ornithine-containing composition

Publications (3)

Publication Number Publication Date
JP2013040142A JP2013040142A (en) 2013-02-28
JP2013040142A5 true JP2013040142A5 (en) 2014-09-04
JP5997425B2 JP5997425B2 (en) 2016-09-28

Family

ID=47888882

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011178937A Active JP5997425B2 (en) 2011-08-18 2011-08-18 Ornithine-containing composition

Country Status (1)

Country Link
JP (1) JP5997425B2 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
DE60312033T2 (en) * 2002-12-06 2007-10-25 Kyowa Hakko Kogyo Co., Ltd. METHOD FOR REDUCING THE BITTERITY OF AMINO ACID
US20060280776A1 (en) * 2003-09-02 2006-12-14 Masafumi Koide Diet food
JP5177785B2 (en) * 2004-11-02 2013-04-10 味の素株式会社 Drugs for perioperative patients
JP5053535B2 (en) * 2005-05-13 2012-10-17 協和発酵バイオ株式会社 Oral for improving sleep or waking up
CN101460159B (en) * 2006-06-07 2011-11-23 协和发酵生化株式会社 Fatigue-reducing agent
JP4847829B2 (en) * 2006-09-25 2011-12-28 協和発酵バイオ株式会社 Vinegar corner control method
WO2008072725A1 (en) * 2006-12-15 2008-06-19 Kyowa Hakko Bio Co., Ltd. Composition containing agaricus blazei murill
JP2008214232A (en) * 2007-03-02 2008-09-18 Kyowa Hakko Kogyo Co Ltd Collagen synthesis promoter
JP2011120479A (en) * 2009-12-08 2011-06-23 Kirin Holdings Co Ltd Basic amino acid-containing packaged beverage

Similar Documents

Publication Publication Date Title
JP2011093933A5 (en)
WO2012084624A9 (en) Compositions of fat-soluble active ingredients containing plant protein-soy polysaccharide complexes
UA114888C2 (en) Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections
WO2013089394A3 (en) Composition of an aqueous solution of polymeric nanoparticles and method for preparing same
MX342700B (en) Nanoparticles for the encapsulation of compounds, preparation thereof and use of same.
MX347022B (en) Confection with gelatin complex.
JP2014530801A5 (en)
NZ591204A (en) Pharmaceutical compositions and methods for stabilizing the same
JP2011530540A5 (en)
MX359362B (en) Iron supplement composition.
WO2011019735A3 (en) Nutritional supplements
WO2012064159A3 (en) Anticancer composition
JP2013040142A5 (en)
JP2016210757A5 (en)
JP2013099341A5 (en)
WO2012077968A3 (en) Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof
HRP20220691T1 (en) Improvements in and relating to compositions
JP5847512B2 (en) Beverage composition
RU2014146562A (en) ALPHA-LIPOIC ACID AND RACNOCIOLE COMPOSITION FOR THE TREATMENT OF NEUROPATHIES
WO2017076711A1 (en) A leachable solid composition and process of manufacture thereof
JP2013066440A (en) Beverage composition
WO2012006321A3 (en) Novel antibacterial compounds, methods of making them, and uses thereof
CN102150924B (en) Alliin-containing antistaling agent and production method thereof
JP2014129321A5 (en)
WO2010003465A3 (en) A drug powder for inhalation administration and a process thereof